Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.

Vaccine - 17 Feb 2016

Kumar Anuj, Das Soma, Mullick Ranajoy, Lahiri Priyanka, Tatineni Ranjitha, Goswami Debashree, Bhat Prasanna, Torresi Joseph, Gowans Eric James, Karande Anjali Anoop, Das Saumitra

Abstract excerpt

Chronic hepatitis C virus (HCV) infection represents a major health threat to global population. In India, approximately 15-20% of cases of chronic liver diseases are caused by HCV infection. Although, new drug treatments hold great promise for HCV eradication in infected individuals, the treatments are highly expensive. A vaccine for preventing or treating HCV infection would be of great value, particularly in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Baculoviridae

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C Antibodies

Share to Immunity, Cellular

Share to Immunity, Humoral

Share to Immunization, Secondary

Share to Neutralization Tests

Share to Viral Hepatitis Vaccines

Source

Identifiers

PMID: 26700891
DOI: 10.1016/j.vaccine.2015.11.061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.PMID 26700891Read ↗

Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice.Semantic proximity Read ↗

Progress in the development of vaccines for hepatitis C virus infection.Semantic proximity Read ↗

A Self-Assembled Viral Protein VP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mice ModelSemantic proximity Read ↗

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt.Semantic proximity Read ↗

Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine DesignSemantic proximity Read ↗

A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.Semantic proximity Read ↗

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.Semantic proximity Read ↗

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis CSemantic proximity Read ↗

Mixing particles from various HCV genotypes increases the HBV-HCV vaccine ability to elicit broadly cross-neutralizing antibodies.Semantic proximity Read ↗

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.Semantic proximity Read ↗

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.Semantic proximity Read ↗

Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.